1. The chick embryo chorioallantoic membrane as a model to study tumor metastasis

   • Anca Maria Cimpean
   • Domenico Ribatti
   • Marius Raica

   Review Paper 09 September 2008 Pages: 311 - 319

   

2. Circulating and imaging markers for angiogenesis

   • Arvind P. Pathak
   • Warren E. Hochfeld
   • Michael S. Pepper

   Review Paper 17 October 2008 Pages: 321 - 335

   

3. Farnesyltransferase inhibitors target multiple endothelial cell functions in angiogenesis

   • Alice N. Scott
   • Clare Hetheridge
   • Harry Mellor

   Original Paper 30 August 2008 Pages: 337 - 346

   

4. A role for planar cell polarity signaling in angiogenesis

   • Pasquale Cirone
   • Shengda Lin
   • Craig M. Crews

   Original Paper 17 September 2008 Pages: 347 - 360

   

5. PPARγ ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis

   • Ahmad Aljada
   • Laura O’Connor
   • Shaker A. Mousa

   Original Paper 23 September 2008 Pages: 361 - 367

   

6. Angiogenic response to extracorporeal shock wave treatment in murine skin isografts

   • Alexander Stojadinovic
   • Eric A. Elster
   • Thomas A. Davis

   Original Paper 09 November 2008 Pages: 369 - 380

   

7. Anti-tumoral effect of active immunotherapy in C57BL/6 mice using a recombinant human VEGF protein as antigen and three chemically unrelated adjuvants

   • Yanelys Morera
   • Mónica Bequet-Romero
   • Jorge V. Gavilondo

   Original Paper 26 November 2008 Pages: 381 - 393

   

8. A nuclease-resistant RNA aptamer specifically inhibits angiopoietin-1-mediated Tie2 activation and function

   • Rebekah R. White
   • Julie A. Roy
   • Christopher D. Kontos

   Brief Communication 27 November 2008 Pages: 395 - 401